文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

高危饮酒与危重症患者急性肾损伤独立相关

At-Risk Drinking Is Independently Associated With Acute Kidney Injury in Critically Ill Patients.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论在ICU成人患者中,高危饮酒与入ICU时及4天内发生2-3期急性肾损伤独立相关(校正OR 2.15),作者认为系统识别酒精滥用可能有助于预防急性肾损伤。

该前瞻性观察性队列研究在单中心21张床的综合性ICU纳入30个月内住院≥3天且可评估酒精摄入的1107例成人患者,比较320例高危饮酒者(29%)与787例非高危饮酒者(71%)。入ICU时2-3期急性肾损伤比例高危饮酒者42.5% vs 非高危饮酒者18%(p<0.0001);校正易感及诱发因素后,入ICU 4天内高危饮酒与急性肾损伤在全人群(OR 2.15;1.60-2.89;p<0.0001)、入ICU时无2-3期急性肾损伤的832例亚组(OR 1.44;1.02-2.02;p=0.04)及无已知慢性肾病的971例亚组(OR 1.92;1.41-2.61;p<0.0001)均独立相关。存活者中,高危饮酒者22% vs 非高危饮酒者9%在出院时仍为2-3期急性肾损伤(p<0.001)。作者认为慢性及当前酒精滥用与危重症患者肾功能障碍相关,系统准确识别酒精滥用可能有助于预防急性肾损伤。

要点

  • 入ICU时2-3期急性肾损伤比例高危饮酒者42.5% vs 非高危饮酒者18%(p<0.0001)。
  • 校正易感及诱发因素后,入ICU 4天内高危饮酒与急性肾损伤独立相关:全人群OR 2.15(1.60-2.89),p<0.0001。
  • 入ICU时无2-3期急性肾损伤的832例亚组中OR 1.44(1.02-2.02),p=0.04;无已知慢性肾病的971例亚组中OR 1.92(1.41-2.61),p<0.0001。
  • 存活者出院时仍为2-3期急性肾损伤者:高危饮酒者22% vs 非高危饮酒者9%(p<0.001)。
  • 作者认为系统准确识别酒精滥用可能有助于预防急性肾损伤。

适用人群与场景

  • 单中心21张床综合性ICU,30个月期间收治的成人患者,ICU停留时间≥3天且可评估酒精摄入者,共1107例。
  • 排除:ICU停留时间<3天或无法评估酒精摄入者(原文纳入标准为ICU停留≥3天且可评估酒精摄入)。

诊断标准与关键阈值

  • 急性肾损伤评估采用肾脏病改善全球预后(KDIGO)2-3期标准,评估时点为入ICU时、入ICU后4天内及出ICU时。
  • 高危饮酒:原文以高危饮酒与非高危饮酒分组,未给出具体饮酒量阈值。

研究设计与关键结果

  • 前瞻性观察性队列研究,单中心21张床综合性ICU,纳入1107例成人患者,其中高危饮酒者320例(29%)、非高危饮酒者787例(71%)。
  • 入ICU时2-3期急性肾损伤比例:高危饮酒者42.5% vs 非高危饮酒者18%(p<0.0001)。
  • 校正急性肾损伤易感及诱发因素后,入ICU 4天内高危饮酒与急性肾损伤在全人群独立相关:OR 2.15(95%CI 1.60-2.89),p<0.0001。
  • 入ICU时无2-3期急性肾损伤的832例亚组中,高危饮酒与急性肾损伤相关:OR 1.44(95%CI 1.02-2.02),p=0.04。
  • 无已知慢性肾病的971例亚组中,高危饮酒与急性肾损伤相关:OR 1.92(95%CI 1.41-2.61),p<0.0001。
  • 存活者出院时仍为2-3期急性肾损伤的比例:高危饮酒者22% vs 非高危饮酒者9%(p<0.001)。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,系统准确地识别危重症患者的酒精滥用可能有助于预防急性肾损伤。
  • 对高危饮酒的ICU患者,入ICU时及入ICU后4天内应关注2-3期急性肾损伤的发生,出院时仍需评估肾功能恢复情况。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Unhealthy use of alcohol and acute kidney injury are major public health problems, but little is known about the impact of excessive alcohol consumption on kidney function in critically ill patients. We aimed to determine whether at-risk drinking is independently associated with acute kidney injury in the ICU and at ICU discharge.

DESIGN: Prospective observational cohort study.

SETTING: A 21-bed polyvalent ICU in a university hospital.

PATIENTS: A total of 1,107 adult patients admitted over a 30-month period who had an ICU stay of greater than or equal to 3 days and in whom alcohol consumption could be assessed.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We assessed Kidney Disease Improving Global Outcomes stages 2-3 acute kidney injury in 320 at-risk drinkers (29%) and 787 non-at-risk drinkers (71%) at admission to the ICU, within 4 days after admission and at ICU discharge. The proportion of patients with stages 2-3 acute kidney injury at admission to the ICU (42.5% vs 18%; p < 0.0001) was significantly higher in at-risk drinkers than in non-at-risk drinkers. Within 4 days and after adjustment on susceptible and predisposing factors for acute kidney injury was performed, at-risk drinking was significantly associated with acute kidney injury for the entire population (odds ratio, 2.15; 1.60-2.89; p < 0.0001) in the subgroup of 832 patients without stages 2-3 acute kidney injury at admission to the ICU (odds ratio, 1.44; 1.02-2.02; p = 0.04) and in the subgroup of 971 patients without known chronic kidney disease (odds ratio, 1.92; 1.41-2.61; p < 0.0001). Among survivors, 22% of at-risk drinkers and 9% of non-at-risk drinkers were discharged with stages 2-3 acute kidney injury (p < 0.001).

CONCLUSIONS: Our results suggest that chronic and current alcohol misuse in critically ill patients is associated with kidney dysfunction. The systematic and accurate identification of patients with alcohol misuse may allow for the prevention of acute kidney injury.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Gacouin A, Lesouhaitier M, Frerou A, et al. At-Risk Drinking Is Independently Associated With Acute Kidney Injury in Critically Ill Patients. Crit Care Med. 2019. PMID: 31094742. doi:10.1097/CCM.0000000000003801

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。